Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children's Oncology Group (COG) Study AALL0331

被引:0
|
作者
Mattano, Leonard A. [1 ]
Devidas, Meenakshi [2 ]
Friedmann, Alison M. [3 ]
Raetz, Elizabeth A. [4 ]
Loh, Mignon [5 ]
Buckley, Patrick [6 ]
Borowitz, Michael J. [7 ]
Carroll, Andrew J. [8 ]
Gastier-Foster, Julie [9 ]
Heerema, Nyla A. [10 ]
Kadan-Lottick, Nina [11 ]
Matloub, Yousif [12 ]
Marshall, David T. [13 ]
Stork, Linda C. [14 ]
Wood, Brent L. [15 ]
Winick, Naomi J. [16 ]
Hunger, Stephen [17 ,18 ]
Carroll, William L. [19 ]
Maloney, Kelly [20 ]
机构
[1] Bronson Methodist Hosp, Kalamazoo, MI USA
[2] Univ Florida, Gainesville, FL USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Primary Childrens Med Ctr, Salt Lake City, UT USA
[5] Dept Pediat Hematol Oncol, San Francisco, CA USA
[6] Duke Univ, Med Ctr, Durham, NC USA
[7] Johns Hopkins Univ, Baltimore, MD USA
[8] Univ Alabama Birmingham, Birmingham, AL USA
[9] Nationwide Childrens Hosp, Columbus, OH USA
[10] Ohio State Univ, Columbus, OH 43210 USA
[11] Yale Univ, Sch Med, New Haven, CT USA
[12] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA
[13] Med Univ S Carolina, Charleston, SC 29425 USA
[14] OR Hlth Sci Univ, Portland, OR USA
[15] Seattle Canc Care Alliance, Seattle, WA USA
[16] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[17] Univ Colorado, Sch Med, Aurora, CO USA
[18] Childrens Hosp, Aurora, CO USA
[19] NYU, Langone Med Ctr, New York, NY USA
[20] Childrens Hosp Colorado, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Poverty during Maintenance and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): A Report from Children's Oncology Group Study (COG-AALL03N1)
    Wadhwa, Aman
    Chen, Yanjun
    Hageman, Lindsey
    Hoppmann, Anna
    Angiolillo, Anne L.
    Dickens, David
    Lew, Glen
    Neglia, Joseph P.
    Ravindranath, Yaddanapudi
    Ritchey, Arthur K.
    Termuhlen, Amanda Muench
    Wong, Lennie
    Landier, Wendy
    Bhatia, Smita
    BLOOD, 2022, 140 : 2183 - 2184
  • [22] Early Response Characteristics and Blast Cytogenetic FEatures In 5,377 Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): A Children's Oncology Group (COG) Study
    Maloney, Kelly W.
    Loh, Mignon L.
    Raetz, Elizabeth
    Borowitz, Michael J.
    Devidas, Meenakshi
    Friedmann, Alison M.
    Mattano, Leonard A.
    Wood, Brent
    Winick, Naomi
    Hunger, Stephen
    Carroll, William L.
    BLOOD, 2010, 116 (21) : 184 - 184
  • [23] Outcomes with reduced intensity therapy in a low-risk subset of children with National Cancer Institute (NCI) standard-risk (SR) B-lymphoblastic leukemia (B-ALL): A report from Children's Oncology Group (COG) AALL0932.
    Schore, Reuven J.
    Angiolillo, Anne J.
    Kairalla, John A.
    Devidas, Meenakshi
    Rabin, Karen R.
    Zweidler-McKay, Patrick A.
    Borowitz, Michael J.
    Wood, Brent L.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Relling, Mary V.
    Hitzler, Johann
    Lane, Ashley R.
    Maloney, Kelly W.
    Wang, Cindy
    Carroll, William L.
    Winick, Naomi J.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Hunger, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Intensified PEG-L-asparaginase and anti metabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia - A report from the Children's Oncology Group
    Salzer, Wanda L.
    Devidas, Meenakshi
    Shuster, Jonathan J.
    Wang, Chenguang
    Chauvenet, Allen
    Asselin, Barbara L.
    Camitta, Bruce M.
    Kurtzberg, Joanne
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (06) : 369 - 375
  • [25] Adverse Reactions to PEG and Erwinia Asparaginase and Correlation with Anti-Asparaginase Antibody Data and Survival in Children with Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group Study CCG 1961
    Dhall, Girish
    Jones, Tamekia
    Radvinsky, David
    Robison, Nathan
    Butturini, Anna
    Rubin, Joan I.
    Gaynon, Paul S.
    Panosyan, Eduard H.
    Avramis, Ioannis A.
    Avramis, Vassilios I.
    Ettinger, Lawrence J.
    Seibel, Nita L.
    BLOOD, 2009, 114 (22) : 1197 - 1197
  • [26] Secondary Chromosomal Abnormalities Appear to Be Less Prognostic for Children with Philadelphia Chromosome Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL) Treated with Intensified Imatinib and Chemotherapy: Results of the Children's Oncology Group (COG) Study AALL0031.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Devidas, Meenakshi
    Bowman, W. Paul
    Wang, Chenguang
    Trigg, Michael
    Camitta, Bruce
    Gaynon, Paul S.
    Winick, Naomi J.
    Hunger, Stephen P.
    Carroll, William L.
    Schultz, Kirk R.
    BLOOD, 2009, 114 (22) : 1022 - 1023
  • [27] Trends in body mass index (BMI) during and after treatment for standard risk (SR) acute lymphoblastic leukemia (ALL): A report from the Children's Oncology Group (COG)
    Lindemulder, Susan Joy
    Stork, Linda C.
    Bostrom, Bruce C.
    Lu, Xiaomin
    Devidas, Meenakshi
    Neglia, Joseph Philip
    Kadan-Lottick, Nina
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Pharmacokinetic (PK) and pharmacodynamics (PD) properties of SC-PEG e. coli L-asparaginase (EZN-2285) in the treatment of patients with acute lymphoblastic leukemia ( ALL): Results from Children's Oncology Group (COG) study AALL07P4.
    Angiolillo, Anne L.
    Schore, Reuven J.
    Reaman, Gregory H.
    Winick, Naomi Joan
    Devidas, Meenakshi
    Zheng, Hao W.
    Wood, Charlotte
    Lane, Ashley R.
    Raetz, Elizabeth A.
    Carroll, William L.
    Hunger, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Osteonecrosis (ON) is Associated with Improved Event Free Survival (EFS) in High-Risk Acute Lymphoblastic Leukemia (HR-ALL): Results of Children's Oncology Group (COG) Study AALL0232
    Mattano, L. A.
    Devidas, M.
    Chen, S.
    Raetz, E.
    Loh, M.
    Winick, N.
    Hunger, S. P.
    Carroll, W. L.
    Larsen, E.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S17 - S17
  • [30] Efficacy and Safety of Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): Complete Follow-up of the Children's Oncology Group (COG) AALL1931 Study
    Maese, Luke
    Loh, Mignon L.
    Choi, Mi Rim
    Lin, Tong
    Aoki, Etsuko
    Agarwal, Shirali
    Chandrasekaran, Vijayalakshmi
    Liang, Yali
    Girgis, Suzette
    Chen, Cuiping
    Iannone, Robert
    Silverman, Lewis B.
    Raetz, Elizabeth A.
    Rau, Rachel E.
    BLOOD, 2023, 142